Literature DB >> 2888763

Biosynthesis of heterogeneous forms of multidrug resistance-associated glycoproteins.

L M Greenberger1, S S Williams, S B Horwitz.   

Abstract

Multidrug-resistant J774.2 mouse macrophage-like cells, selected for resistance to colchicine, vinblastine, or taxol, overexpress antigenically related glycoproteins with distinct electrophoretic mobilities. These plasma membrane glycoproteins are likely to play a pivotal role in the expression of the multidrug resistance phenotype. To determine how these multidrug resistance-associated glycoproteins differ, the biosynthesis and N-linked carbohydrate composition of these proteins were examined and compared. Vinblastineor colchicine-selected cells made a 125-kDa precursor that was rapidly processed (t1/2 approximately equal to 20 min) to mature forms of 135 and 140 kDa, respectively. Heterogeneity between the 135- and 140-kDa forms of the molecule can be attributed to N-linked carbohydrate. In contrast, taxol-selected cells made two precursors, 125 and 120 kDa, which appeared within 5 and 15 min after the onset of pulse labeling, respectively. They were processed to mature forms of 140 and 130 kDa. Since a single deglycosylated precursor or mature form was not observed after enzymatic removal of N-linked oligosaccharides, other differences, besides N-linked glycosylation, which occur in early processing compartments, are likely to account for the two multidrug resistance-associated glycoproteins in taxol-selected cells. These results demonstrate that a family of multidrug resistance-associated glycoproteins can be differentially expressed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888763

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Structural analysis of the mouse mdr1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774.2 cells.

Authors:  S I Hsu; D Cohen; L S Kirschner; L Lothstein; M Hartstein; S B Horwitz
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

2.  Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells.

Authors:  M Raymond; E Rose; D E Housman; P Gros
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

3.  Cloning and characterization of a second member of the mouse mdr gene family.

Authors:  P Gros; M Raymond; J Bell; D Housman
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

Review 4.  Genetics of multidrug resistance.

Authors:  J M Croop; P Gros; D E Housman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

5.  Pharmacological and molecular characterization of intrinsic and acquired doxorubicin resistance in murine tumor cell lines.

Authors:  B Schott; D Londos-Gagliardi; C Ries; S Huet; J Robert
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 6.  Differing patterns of cross-resistance resulting from exposures to specific antitumour drugs or to radiation in vitro.

Authors:  B T Hill
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

7.  Distinct P-glycoprotein precursors are overproduced in independently isolated drug-resistant cell lines.

Authors:  L M Greenberger; L Lothstein; S S Williams; S B Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

8.  Essential role of a sodium dodecyl sulfate-resistant protein IV multimer in assembly-export of filamentous phage.

Authors:  N A Linderoth; P Model; M Russel
Journal:  J Bacteriol       Date:  1996-04       Impact factor: 3.490

9.  Functional studies with a full-length P-glycoprotein cDNA encoded by the hamster pgp1 gene.

Authors:  S E Devine; P W Melera
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  11a-N-Tosyl-5-deoxi-pterocarpan, LQB-223, a novel compound with potent antineoplastic activity toward breast cancer cells with different phenotypes.

Authors:  Lauana Greicy Tonon Lemos; Gabriela Nestal de Moraes; Deborah Delbue; Flavia da Cunha Vasconcelos; Paula Sabbo Bernardo; Eric W-F Lam; Camilla Djenne Buarque; Paulo Ribeiro Costa; Raquel Ciuvalschi Maia
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-12       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.